MaaT Pharma has revealed a study into its faecal microbiota transfer process can benefit patients with Acute Myeloid Leukaemia (AML) by re-establishing their gut microbiome post-chemotherapy.
As the industry heads into Autumn, nutrition and ingredient firms look to end an eventful 2020 strongly, with the right people employed in key positions. Here, Nutraingredients rounds up the appointments made for September.
French oncology firm, MaaT Pharma announces its intention to resume collection of donor stools as part of its microbiome-based research into tackling blood cancers, such as Acute Myeloid Leukaemia (AML).
